COMPANY ANNOUNCEMENTPremier Bionics to list on AIM18th October...

COMPANY ANNOUNCEMENT
Premier Bionics to list on AIM
18th October 2005: Premier Bionics is pleased to announce that it is to seek a listing of the
Company’s securities on the Alternative Investment Market (AIM). In accordance with AIM rules,
the Company has today released to the London Stock Exchange a 20 business day notice of its
intention to seek admission on AIM (“Admission”).
The Company’s ordinary shares (ASX : PBI) and listed options (ASX : PBIO) will continue to be
traded on the ASX. Following Admission, they will also be traded on AIM. It is expected that
Admission will take place on or around 16th November 2005.
Further information regarding the Company’s Admission to AIM can be found in the Pre-
Admission Announcement and Appendix, both of which have been submitted to the London Stock
Exchange and are available, together with further information, at www.premierbionics.com.au.
Premier Bionics is seeking dual listing on AIM for a number of key strategic reasons. In
particular, significant growth opportunities have been identified for the company’s 100% owned
subsidiary Medic Vision. Medic Vision is embarking upon an expansion of sales of its virtual
reality surgical simulators and skills centre development projects in the UK and European markets
as part of its positioning to become a leader in this emerging field.
The dual listing of Premier Bionics shares on AIM will result in greater international exposure for
the Company and offers the opportunity to gain direct access to the United Kingdom’s capital
markets. Corporate Synergy Plc has been appointed NOMAD/Broker. Over the next few weeks
the Company will be making available to all shareholders additional information in respect of this
important phase in its development.
For further information contact:
Peter Marks, Executive Chairman: 03 9824 8166
Ross Horley, CEO, Medic Vision: 0400 209 899